Not available
Quote | Blackrock MuniYield Fund Inc. (NYSE:MYD)
Last: | $10.86 |
---|---|
Change Percent: | -0.18% |
Open: | $10.85 |
Close: | $10.86 |
High: | $10.87 |
Low: | $10.82 |
Volume: | 134,720 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Blackrock MuniYield Fund Inc. (NYSE:MYD)
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the Great Place To Work Certification for the second year in a row. The certification is based entirely on what curre...
SALT LAKE CITY, June 24, 2024 (GLOBE NEWSWIRE) -- A significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season according to the latest GeneSight ® Mental Health Monitor: Special Election Series, a nationwide survey from Myria...
Message Board Posts | Blackrock MuniYield Fund Inc. (NYSE:MYD)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $MYD News Article - BlackRock to Host Municipal Closed-End Fund Update Call on April 6, | whytestocks | investorshangout | 04/05/2023 8:40:47 PM |
$MYD Chart http://www.stockscores.com/chart.as | $Pistol Pete$ | investorshub | 02/13/2016 3:40:22 AM |
Stock_Tracker: Latest Blackrock Muniyield Fund (MYD) Headlines Distribution Dates and Amounts Announ | Stock_Tracker | investorshangout | 03/14/2014 10:05:49 AM |
chartguy89: MYD Stock Charts Last: UNCH Tuesday, March 4, 2014 at 12:56:04 AM $MYD 1 Month C | chartguy89 | investorshangout | 03/04/2014 5:56:15 AM |
News, Short Squeeze, Breakout and More Instantly...
Blackrock MuniYield Fund Inc. Company Name:
MYD Stock Symbol:
NYSE Market:
Blackrock MuniYield Fund Inc. Website:
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the Great Place To Work Certification for the second year in a row. The certification is based entirely on what curre...
SALT LAKE CITY, June 24, 2024 (GLOBE NEWSWIRE) -- A significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season according to the latest GeneSight ® Mental Health Monitor: Special Election Series, a nationwide survey from Myria...
SALT LAKE CITY, June 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at improving access to homologous recombination deficiency (HRD) diagnostic testing for high-grade serous ...